About Vertex Pharmaceuticals Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases.

Following our analysis of the options activities associated with Vertex Pharmaceuticals, we pivot to a closer look at the company's own performance. Where Is Vertex Pharmaceuticals Standing Right Now?

Shares of Vertex Pharmaceuticals Inc. VRTX slipped 1.34% to $463.27 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0. ...

Vertex Pharmaceuticals VRTX has outperformed the market over the past 10 years by 1.83% on an annualized basis producing an average annual return of 13.39%. Currently, Vertex Pharmaceuticals has a ...

Vertex Pharmaceuticals Incorporated remains a top Buy with a strong cystic fibrosis franchise, innovative pipeline, and cell therapies. Click for my VRTX update.

Partnership Rhode Island describes itself as a nonprofit "CEO roundtable" of leaders from RI's largest employers.

The last time Rhode Island FC put the ball in the net was the 44th minute of its July 5 matchup with Birmingham Legion.

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) is one of Goldman Sachs’ top healthcare stock picks. On July 1, the European Commission approved the company’s new cystic fibrosis treatment ...

The Motley Fool has positions in and recommends AbbVie, Abbott Laboratories, and Vertex Pharmaceuticals. The Motley Fool has a disclosure policy.